Net-Net Stock - cheap stock I recently bought this company.
Pretty cheap stock by any standard. Looks very similar to CPH, IBT and MPH pharma plays. Management has began the turnaround, so Revenue and Profit should trend higher Y-o-Y.
In a nutshell, as of August 12 2023 :
- EV : 4M$
- Market Cap : 14 M$
- No Debt
- Cash per share : 0.50$ (10.2M$)
- Ebitda : 1.9M$ (TTM)
- EV/Enitda : 2.1x
- Net Current Asset Value (net net stock) : 0.73$ / share
- Book Value per share : 1.01$
- EPS : positive, trending higher Y-O-Y
- Stock Price : 0.70$ per share
We will see what will happen, however I believe the downside is very limited.
GLTA !